Wednesday, June 22, 2016
- 12:00pm-1:30pm
-
Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Changes in motor symptoms of Parkinson’s disease: 2-year follow-up of 735 cases
Rating scales · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Changes of brain structure and cognition in individuals with possible prodromal Parkinson’s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Characterization and quantitative analysis of prelemniscal radiations in Parkinson´s disease
Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Children with intractable temporal and extratemporal seizures: Correlation of the MR spectroscopy and EEG findings in the surgical planning
Neuroimaging (non-PD) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Chorea-acanthocytosis: The first described clinical case in Ukraine
Choreas (non-Huntington's disease) · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Choreoathetosis associated with cervical dystonia as clinical presentation of thyrotoxicosis: A rare condition
Phenomenology and clinical assessment of movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Circulatory levels of BDNF correlate with cognitive deficits in people with Parkinson’s disease
Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2
- 12:00pm-1:30pm
-
Clinical and analytical validation of novel autosomal recessive ataxia mutations identified from whole exome sequencing
Ataxia · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 54
- Next Page»